<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ISOSORBIDE</span><br/>(eye-soe-sor'bide)<br/><span class="topboxtradename">Ismotic<br/></span><b>Classifications:</b> <span class="classification">osmotic diuretic</span>; <span class="classification">antiglaucoma</span><br/><b>Prototype: </b>Mannitol<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>45% solution</p>
<h1><a name="action">Actions</a></h1>
<p>Actions similar to those of other osmotic agents, e.g., mannitol, but produces greater diuresis and does not cause hyperglycemia.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Reduces intraocular pressure (IOP) by increasing plasma osmotic pressure.</p>
<h1><a name="uses">Uses</a></h1>
<p>Short-term emergency treatment of acute angle-closure glaucoma and for reducing IOP before and after surgery for glaucoma
         and cataract.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to isosorbide; severe renal disease, anuria; severe dehydration; frank or impending pulmonary edema; hemorrhagic
         glaucoma. Safe use during pregnancy (category B) is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Diseases associated with sodium retention, lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Acute Angle-closure Glaucoma</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 13 g/kg b.i.d. to q.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Pour over ice and have patient sip in order to make more palatable.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache, lethargy, vertigo, dizziness, light-headedness, syncope, <span class="speceff-common">confusion, disorientation,</span> irritability. <span class="typehead">GI:</span> <span class="speceff-common">Nausea, vomiting,</span> diarrhea, anorexia, gastric discomfort, thirst. <span class="typehead">Respiratory:</span> Hiccups. <span class="typehead">Skin:</span> Rash. <span class="typehead">Metabolic:</span> Hypernatremia, hyperosmolality. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 30 min. <span class="typehead"> Peak:</span> 11.5 h. <span class="typehead">Duration:</span> Up to 56 h. <span class="typehead">Elimination:</span> Eliminated unchanged in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor fluid and electrolyte balance carefully.</li>
<li>Monitor IOP frequently.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Keep follow-up appointments.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>